UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052844
Receipt number R000060301
Scientific Title Relevance of conventional and objective assessment of soft tissue for the transfemoral amputees.
Date of disclosure of the study information 2023/11/21
Last modified on 2023/11/19 20:37:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relevance of conventional and objective assessment of soft tissue for the transfemoral amputees.

Acronym

Relevance of conventional and objective assessment of soft tissue for the transfemoral amputees.

Scientific Title

Relevance of conventional and objective assessment of soft tissue for the transfemoral amputees.

Scientific Title:Acronym

Relevance of conventional and objective assessment of soft tissue for the transfemoral amputees.

Region

Japan


Condition

Condition

femoral amputation

Classification by specialty

Orthopedics

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to elucidate the relationship between conventional "evaluation" and "objective evaluation" in the evaluation of soft tissue at the time of femoral prosthesis socket fabrication. At the same time, to compare the values of the "objective evaluation" between femoral amputees and male students, and to help in the creation of femoral prosthetic sockets.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

・Soft Tissue Evaluation of Broken Ends
Conventional evaluation using VAS (evaluation by prosthetist)
Quantitative evaluation using ultrasound imaging system (evaluation by principal investigator)
・Evaluation of the length of the transected end
Conventional evaluation using VAS (evaluation by prosthetist)
Quantitative evaluation using a femoral prosthesis disc gauge (evaluation by principal investigator)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

The duration of the intervention is one day and the number of interventions is one day. The flexibility will be measured using a diagnostic ultrasound device.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

Femoral amputees. The study will be conducted on those who understand the content of the study and agree to participate in it. The healthy subjects will be those who understand the content of the study and agree to participate in it.

Key exclusion criteria

Subjects will be excluded from the study if they are unable to give consent to participate in the study.

Target sample size

25


Research contact person

Name of lead principal investigator

1st name kazuto
Middle name
Last name kamiwaki

Organization

Niigata University of Health and Welfare

Division name

Major in Medical and Rehabilitation Sciences

Zip code

950-3102

Address

1398 Shimami-cho, Kita-ku, Niigata City, Niigata Prefecture

TEL

070-2816-2169

Email

ham22001@nuhw.ac.jp


Public contact

Name of contact person

1st name kazuto
Middle name
Last name kamiwaki

Organization

Niigata University of Health and Welfare

Division name

Major in Medical and Rehabilitation Sciences

Zip code

950-3102

Address

1398 Shimami-cho, Kita-ku, Niigata City, Niigata Prefecture

TEL

070-2816-2169

Homepage URL


Email

ham22001@nuhw.ac.jp


Sponsor or person

Institute

Niigata University of Health and Welfare

Institute

Department

Personal name



Funding Source

Organization

Niigata University of Health and Welfare

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Niigata University of Health and Welfare

Address

1398 Shimami-cho, Kita-ku, Niigata City, Niigata Prefecture

Tel

070-2816-2169

Email

ham22001@nuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2023 Year 11 Month 19 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 11 Month 19 Day

Last modified on

2023 Year 11 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060301